| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 12 |
| 1 | METHOTREXATE SODIUM | 5 |
| 2 | ATORVASTATIN CALCIUM | 4 |
| 3 | MEPOLIZUMAB | 4 |
| 4 | METHOTREXATE | 4 |
| 5 | ROSUVASTATIN | 4 |
| 6 | ACETAMINOPHEN | 3 |
| 7 | ACETAMINOPHEN 500MG | 3 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 9 | ADALIMUMAB-AATY | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFIXIME | 3 | 0.0010 |
| 1 | CEFDINIR | 1 | 0.0001 |
| 2 | CAPTOPRIL | 1 | 0.0001 |
| 3 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 4 | GOLIMUMAB | 1 | 0.0001 |
| 5 | MEPOLIZUMAB | 4 | 0.0001 |
| 6 | ROSUVASTATIN CALCIUM | 2 | 0.0001 |
| 7 | ADALIMUMAB-FKJP | 3 | 0.0001 |
| 8 | OXCARBAZEPINE | 1 | 0.0001 |
| 9 | ADALIMUMAB-AATY | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 3 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 4 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 7 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | RANK Ligand Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |